Zelnorm (tegaserod maleate) - Product withdrawn from the market. Study results showed patients on Zelnorm (marketed as ZelmacTM in SIngapore by Novartis) had higher risk of serious cardiovascular adverse events. (Posted 30/3/2007)
Permax (pergolide) and generic equivalents - Products withdrawn from the market. New studies showed that some patients with Parkinson's disease treated with pergolide (marketed as CelanceTM by PL Asia Pacific in Singapore) had serious damage to their heart valves. (Posted 29/3/2007)
Accutane (isotretinoin) - Special webpage launched to warn consumers and healthcare professionals about the dangers of buying isotretinoin (marketed as RoaccutaneTM by Roche or other generic brands in SIngapore) online. (Posted 28/3/2007)
**********
